Researchers from the world over are working to create prophylactic and therapeutic
interventions to combat the COVID-19 global healthcare crisis. The current therapeutic …

Facing the COVID-19 global healthcare crisis, scientists worldwide are collaborating to
develop prophylactic and therapeutic interventions against the disease. Antibody …

SARS-CoV-2 antibody therapeutics are being evaluated in clinical and preclinical stages. As
of 11 October 2020, 13 human monoclonal antibodies targeting the SARS-CoV-2 spike …

The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …

The rapid spread of severe acute respiratory coronavirus syndrome 2 (SARS-CoV-2) in the
population and throughout the cells within our body has been developing. Another major …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is the largest health crisis
ever faced worldwide. It has resulted in great health and economic costs because no …

The outbreak of COVID-19, the disease caused by infection of the coronavirus SARS-CoV-2
that began in December 2019 in Wuhan, China, has caused more than 2 990 559 confirmed …

Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …

The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …